Short Stature Clinical Trial
Official title:
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Verified date | December 2019 |
Source | Rabin Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Study design: Double blind, randomized, placebo controlled study. Participants will be randomly assigned either to the intervention group or the placebo control group. Randomization for the two study groups will be made in a ratio of 1:1. The primary objective of the study is to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean boys adolescents on weight Standard Deviation Score (SDS) and height SDS The Secondary Objectives of the study are to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean boys adolescents on BMI SDS, growth velocity, time to puberty, quality of life and self-esteem The study will continue for 6 months of intervention versus active placebo, with additional optional 6 months (an extension period), in which participants at both groups, the intervention and the placebo, will be offered to continue their participation in the study with the study supplement. All analyses of the effect's on primary and secondary outcome measurements will take into account the consumption rate of the study formula/placebo
Status | Completed |
Enrollment | 160 |
Est. completion date | February 1, 2021 |
Est. primary completion date | February 1, 2021 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 10 Years to 15 Years |
Eligibility | Inclusion Criteria: - Boys aged =10years old - Prepubertal - Tanner stage 1 (gonadarche) (testicular volume<4) - Height and weight = 10th percentile for age and gender. - Height-SDS = -2.5 SDS - BMI-SDS>-3 SDS - Low proportion between weight and height - Signing inform consent forms Exclusion Criteria: - Diagnosis of Growth Hormone (GH) Deficiency or treatment with GH - Any known chronic disease or dysmorphic syndrome including: bone diseases, organic brain diseases, neurological disease, past or current malignancy, chronic cardiac, renal or pulmonary problems - Any known gastrointestinal disease including malabsorption - Any known organic reason for growth retardation |
Country | Name | City | State |
---|---|---|---|
Israel | Soroka Medical Center | Be'er Sheva' | |
Israel | Schneider Medical Center | Petach- Tikva | |
Israel | Assaf Harofe Medical Center | Rishon Letsiyon |
Lead Sponsor | Collaborator |
---|---|
Rabin Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Time to puberty initiation (Duration of time until testicular volume is at tanner stage >=2) | Duration of time until testicular volume is at tanner stage >=2 | At 12 months | |
Other | Sleep assessment Questionnaire | At 12 Months | ||
Other | Sleep assessment Questionnaire | At 6 Months | ||
Other | Physical Activity Questionnaire | At 12 months | ||
Other | Study Participation Questionnaire | At 6 months | ||
Other | Study Participation Questionnaire | At 12 months | ||
Other | Family Eating and Activity Habits Questionnaire | At 6 months | ||
Other | Family Eating and Activity Habits Questionnaire | At 12 months | ||
Other | Parents Stands Towards Healthy Lifestyle Questionnaire | At 6 months | ||
Other | Parents Stands Towards Healthy Lifestyle Questionnaire | At 12 months | ||
Primary | Weight SDS (standard deviation score) | At 12 months | ||
Primary | Height SDS (standard deviation score) | At 12 months | ||
Primary | Weight SDS (standard deviation score) | At 6 months | ||
Primary | Height SDS (standard deviation score) | At 6 months | ||
Secondary | BMI SDS (standard deviation score) | At 12 months | ||
Secondary | BMI SDS (standard deviation score) | At 6 months | ||
Secondary | Growth velocity | At 12 months | ||
Secondary | Growth velocity | At 6 months | ||
Secondary | Quality of life | Quality of life measured by Quality of Life Questionnaire | At 12 months | |
Secondary | Quality of life | Quality of life measured by Quality of Life Questionnaire | At 6 months | |
Secondary | Self-esteem (Self-Esteem Questionnaire) | Self-esteem measured by Self-Esteem Questionnaire | At 12 months | |
Secondary | Self-esteem (Self-Esteem Questionnaire) | Self-esteem measured by Self-Esteem Questionnaire | At 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT00235599 -
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
|
N/A | |
Completed |
NCT01911260 -
Weekly Zinc Chelate Supplementation on Children's Growth
|
Phase 2/Phase 3 | |
Completed |
NCT02137538 -
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
|
Phase 4 | |
Recruiting |
NCT01934270 -
Growth Hormone Secretion Following the Anaerobic Exercise
|
N/A | |
Completed |
NCT00443144 -
D3-GHR Polymorphism and Turner Syndrome
|
N/A | |
Recruiting |
NCT06295341 -
Short Stature and Psychological Well-being
|
||
Recruiting |
NCT05849389 -
Vosoritide for Short Stature in Turner Syndrome
|
Phase 2 | |
Recruiting |
NCT05829252 -
Testing the Feasibility of a Novel Growth Monitoring Smartphone App
|
||
Withdrawn |
NCT03323177 -
Long Term Effects of Nutritional Supplementation on Final Height
|
N/A | |
Recruiting |
NCT06294860 -
Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
|
||
Recruiting |
NCT03123003 -
Bone Age Assessment in Children Using Ultrasound Compared to Wrist X-ray
|
N/A | |
Completed |
NCT03575221 -
Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation
|
||
Terminated |
NCT01237041 -
Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
|
Phase 1/Phase 2 | |
Completed |
NCT04244123 -
Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
|
||
Recruiting |
NCT01901666 -
Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
|
Phase 4 | |
Withdrawn |
NCT01970800 -
The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
|
N/A | |
Completed |
NCT00830141 -
Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children
|
N/A | |
Completed |
NCT00562705 -
Effects of Growth Hormone (GH) Treatment on Eating Regulation
|
N/A | |
Completed |
NCT00373386 -
Growth Hormone and Endothelial Function in Children
|
Phase 4 |